PE20030207A1 - Soluciones de acido acetilsalicilico - Google Patents
Soluciones de acido acetilsalicilicoInfo
- Publication number
- PE20030207A1 PE20030207A1 PE2001000218A PE2001000218A PE20030207A1 PE 20030207 A1 PE20030207 A1 PE 20030207A1 PE 2001000218 A PE2001000218 A PE 2001000218A PE 2001000218 A PE2001000218 A PE 2001000218A PE 20030207 A1 PE20030207 A1 PE 20030207A1
- Authority
- PE
- Peru
- Prior art keywords
- volume
- acid solutions
- solvent
- solution
- water
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 abstract 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 abstract 2
- 239000003960 organic solvent Substances 0.000 abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- KFZMGEQAYNKOFK-YZRHJBSPSA-N (214C)propan-2-ol Chemical compound [14CH](C)(C)O KFZMGEQAYNKOFK-YZRHJBSPSA-N 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- LFQSCWFLJHTTHZ-HQMMCQRPSA-N Ethanol-14C Chemical group C[14CH2]O LFQSCWFLJHTTHZ-HQMMCQRPSA-N 0.000 abstract 1
- 208000007514 Herpes zoster Diseases 0.000 abstract 1
- 201000009053 Neurodermatitis Diseases 0.000 abstract 1
- 239000001273 butane Substances 0.000 abstract 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 abstract 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 abstract 1
- 239000001294 propane Substances 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
SE REFIERE A SOLUCIONES DE 3g A 30 g DE ACIDO ACETILSALICILO, CONTENIENDO EL DISOLVENTE DE 1 A 20% EN VOLUMEN DE AGUA Y 80 A 99% EN VOLUMEN DE DISOLVENTE ORGANICO EN 100 ml DE SOLUCION. EL DISOLVENTE ORGANICO SE SELECCIONA DE ETANOL, PROPANO, ISOPROPANOL, BUTANO, ISOBUTANOL, ENTRE OTROS. EL DISOLVENTE COENTINE DE 30% A 80% DE VOLUMEN DE ETER , DE 17% A 67% DE VOLUMEN DE ALCOHOL O ACETONA Y DE 3% A 10% EN VOLUMEN DE AGUA. LA SOLUCION ES UTIL PARA EL TRATAMIENTO TOPICO DEL DOLOR COMO HERPES ZOSTER, PRURITO, NEURODERMITIS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10011032A DE10011032A1 (de) | 2000-03-07 | 2000-03-07 | Acetylsalicylsäure-Lösungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030207A1 true PE20030207A1 (es) | 2003-04-16 |
Family
ID=7633806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2001000218A PE20030207A1 (es) | 2000-03-07 | 2001-03-06 | Soluciones de acido acetilsalicilico |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1263441A2 (es) |
| AR (1) | AR028237A1 (es) |
| AU (1) | AU2001272099A1 (es) |
| DE (1) | DE10011032A1 (es) |
| GT (1) | GT200100035A (es) |
| HN (1) | HN2001000039A (es) |
| PE (1) | PE20030207A1 (es) |
| SV (1) | SV2002000339A (es) |
| WO (1) | WO2001066115A2 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070196460A1 (en) * | 2004-02-16 | 2007-08-23 | Yukiko Inamoto | External preparation for treating skin or mucosal injury caused by viral infection |
| WO2007125492A2 (en) * | 2006-05-02 | 2007-11-08 | Pfeinsmith S.A. (Pty) Ltd | Acidic composition |
| JP7335232B2 (ja) * | 2017-05-30 | 2023-08-29 | ローシャン ファーマシューティカルズ,インコーポレーテッド | 安定な滅菌性且つ結晶性o-アセチルサリチル酸(アスピリン)のバイアル内堆積物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4219548A (en) * | 1978-09-01 | 1980-08-26 | The Procter & Gamble Company | Topical anti-inflammatory composition |
| IL68965A (en) * | 1983-06-13 | 1987-02-27 | Rafa Labor Ltd | Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders |
| WO1995019759A1 (en) * | 1994-01-24 | 1995-07-27 | The Procter & Gamble Company | Process for solubilizing difficultly soluble pharmaceutical actives |
| US5484606A (en) * | 1994-01-24 | 1996-01-16 | The Procter & Gamble Company | Process for reducing the precipitation of difficulty soluble pharmaceutical actives |
-
2000
- 2000-03-07 DE DE10011032A patent/DE10011032A1/de not_active Withdrawn
-
2001
- 2001-03-01 EP EP01956187A patent/EP1263441A2/de not_active Withdrawn
- 2001-03-01 WO PCT/EP2001/002282 patent/WO2001066115A2/de not_active Ceased
- 2001-03-01 AU AU2001272099A patent/AU2001272099A1/en not_active Abandoned
- 2001-03-02 GT GT200100035A patent/GT200100035A/es unknown
- 2001-03-05 HN HN2001000039A patent/HN2001000039A/es unknown
- 2001-03-06 PE PE2001000218A patent/PE20030207A1/es not_active Application Discontinuation
- 2001-03-07 SV SV2001000339A patent/SV2002000339A/es not_active Application Discontinuation
- 2001-03-07 AR ARP010101068A patent/AR028237A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1263441A2 (de) | 2002-12-11 |
| AR028237A1 (es) | 2003-04-30 |
| AU2001272099A1 (en) | 2001-09-17 |
| GT200100035A (es) | 2001-12-18 |
| HN2001000039A (es) | 2001-07-09 |
| WO2001066115A3 (de) | 2002-02-14 |
| WO2001066115A2 (de) | 2001-09-13 |
| SV2002000339A (es) | 2002-06-07 |
| DE10011032A1 (de) | 2001-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE49296A1 (es) | Procedimiento para preparar clorhidrato de 1-(2`-desoxi-2',2'-difluoro-d-ribofuranosil)-4-aminopirimidin-2-ona | |
| MD1587B2 (en) | Retinoid composition and utilization thereof as therapeutic remedy for topical cutaneous application | |
| ES2052518T3 (es) | Agente viricida con efecto de amplio espectro. | |
| PE20050945A1 (es) | Ester de rapamicin-42 amorfo con el acido 3-hidroxi-2-(hidroximetil)-2-metilpropionico y sus composiciones farmaceuticas | |
| BRPI0307117B8 (pt) | amidas de ácido antranílico e seus derivados, bem como seus usos como compostos ativos cosméticos e farmacêuticos | |
| DE3579337D1 (de) | Dermatologische fungizide loesung. | |
| AU1018992A (en) | Cosmetic composition | |
| ES2125535T5 (es) | Mezclas, que contienen isocianatos emulsionables en agua. | |
| PE20030207A1 (es) | Soluciones de acido acetilsalicilico | |
| FR2461499A1 (fr) | Composition pharmaceutique a base d'extraits de myrtille | |
| IT1265001B1 (it) | Composizione farmaceutica per uso topico contenente acido (s)-2-(4- isobutilfenil) propionico | |
| ES2143443T3 (es) | Espesantes polimeros para composiciones acuosas. | |
| ES2197632T3 (es) | Procedimiento de preparacion de aloina por extraccion. | |
| ATE376427T1 (de) | Pharmazeutische zusammensetzungen aus bartflechten (usnea barbata) und johanniskraut (hypericum perforatum) sowie ihre verwendung | |
| Dubasi et al. | Applications of Alum (KAl (SO4) 2.12 H2O) in organic synthesis and as catalysis: a quinquennial update (2017-2022) | |
| AR010178A1 (es) | Preparados farmaceuticos que contienen como principio activo cilansetron, empleo de aditivos y procedimiento para la produccion de dichos preparados | |
| CA2067807A1 (en) | Alcoholic aqueous gel-type phospholipid composition, its use and topical preparations containing it | |
| ES2078054T3 (es) | Curtientes diluibles de triformiato de aluminio en forma altamente concentrada soluble en agua y estable al almacenamiento y su empleo. | |
| BR9807056A (pt) | Uso de álcool diclorobenzìlico, e preparação para tratamento tópico da inflamação | |
| ES8705463A1 (es) | Un procedimiento para la preparacion de 1-metil-4,5-dihi- droorotil-histidil-prolinamida | |
| CY1107814T1 (el) | Θεραπεια παθησεων υπερπολλαπλασιασμου των επιφανειων του σωματος | |
| JPS5655307A (en) | Opacifying cosmetic | |
| GT196808903A (es) | Compuestos organicos y proceso. | |
| Ali et al. | Screening for the antimicrobial properties of the leaves of Calophyllum inophyllum Linn.(Guttiferae) | |
| GB1455613A (en) | Antibiotic a-287 and process for production thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |